← All themes
Theme

Distressed / Turnaround

Every analyzed stock in Distressed / Turnaround — 261 companies. Each card shows price, our model's intrinsic value (IV), and how far price sits above or below it. Click any card for the full analysis. This is a research-triage view, not a buy/sell signal.

Distressed / Turnaround risk
Near-term vs. long-term risk for this theme
⚡ Right now ?Near-term risk over roughly the next 3 months. Blends live market conditions (volatility, how far the S&P is from its highs, credit spreads, the yield curve, sentiment), how stretched valuations are, and what the smart money is doing. Higher = greater odds of a pullback. · next 0–3 months
53 /100 Elevated ▼ -2 slight
Long-term risk ?Long-term / structural risk — the market's underlying tide. Where valuations sit versus 145 years of history (Shiller CAPE) plus multi-year trends. A high reading means weak long-run return prospects even if the market feels calm right now. · structural · vs 145yr history
78 /100 High ◆ flat
▲ / ▼ = change vs ~7 days ago — red = risk rising, green = falling.
Inside the "right now" score — a 45 / 30 / 25 blend · 23 stocks valued
Conditions · 45% ?The live market weather: VIX (expected volatility), how far the S&P 500 is below its 52-week high, high-yield credit spreads, the 10-year vs 2-year yield curve, and the Fear & Greed index. Market-wide indices, not per-stock.
28 Moderate
Valuation · 30% ?How expensive stocks are versus our intrinsic-value models: the median price-to-value ratio and the share of stocks trading above what we think they are worth, across 23 stocks.
87 Extreme
Smart money · 25% ?What informed money is doing: short-selling activity plus corporate insiders buying or selling their own stock. Broken out below.
33 Moderate
Smart money — the three inputs
Short-selling ?Share of ALL US trading volume that is short sales (FINRA, ~12,000 symbols, market-wide). It normally sits near 45–50%, so readings above ~50% lean bearish and read as higher risk. Weighted 40% of Smart money.
44.0%
Moderate
Buyers' strike ?Share of the sampled companies whose insiders bought NONE of their own stock on the open market in the last 12 months. The higher this runs, the more bearish (nobody's buying the dip in their own shares). Weighted 35%.
43%
Elevated
Net insider selling ?Share of the sampled companies whose insiders were net DISCRETIONARY sellers over 12 months (excludes scheduled 10b5-1 plans, which carry little signal). Around half is normal; well above that is bearish. Weighted 25%.
22%
Moderate
Black number = the raw figure; coloured bar & word = how it reads as risk. Insider inputs from 236 stocks (full universe); short-selling is market-wide.
Long-term risk: the long-term read runs high mainly because valuations sit near a historic extreme (Shiller CAPE) — a structural backdrop, not about this week.
Scale (0–100): 0–20 Low · 20–40 Moderate · 40–60 Elevated · 60–80 High · 80–100 Extreme. "Right now" reads today's conditions; the "long-term" score is anchored to ~145 years of valuation history.
Educational use only — not investment advice. "Undervalued / fairly valued / overvalued" and every risk score reflect our models vs. price, which can be wrong or based on stale or incomplete data. Always review the company's own financials and SEC filings, and consult a licensed advisor, before acting.
Sort by: A–Z Riskiest Most overvalued Most shorted Buyers' strike Largest
This week in Distressed / Turnaround
Distressed / Turnaround — Aug 10 – Aug 14, 2026 (Wk 33): Distressed/Turnaround Theme: No Insider Buys, Risk Score Stable Amid Elevated Valuations →
This week saw no significant news events for the Distressed/Turnaround theme. SAVNG's risk score for the theme remained elevated at 55/100, with median valuations at 1.72 times model value. No open-market insider buying was recorded, and…
AACG
ATA Creativity Global
Valuation N/A
Consumer Defensive Risk 44 · Elevated
Price$0.86
Model IV—
P/IV—
Market implies +21.7%/yr vs model +4.8% · above model
AFRI
Forafric Global PLC
Valuation N/A
Consumer Defensive Risk 40 · Elevated
Price$11.18
Model IV—
P/IV—
Market implies +1.0%/yr vs model +2.0% · in line
AGIG
ABUNDIA GLOBAL IMPACT GROUP, INC.
Valuation N/A
Energy Risk 55 · Elevated
Price$0.90
Model IV—
P/IV—
Market implies +21.5%/yr vs model +0.0% · above model
AGPU
Axe Compute Inc.
Valuation N/A
Financial Services Risk 31 · Moderate
Price$8.35
Model IV—
P/IV—
Market implies +132.2%/yr vs model +2.0% · above model
AIRO
AIRO Group Holdings, Inc.
Valuation N/A
Industrials Risk 42 · Elevated
Price$7.86
Model IV—
P/IV—
Limited data — see page
AISP
Airship AI Holdings, Inc.
Valuation N/A
Technology Risk 27 · Moderate
Price$2.07
Model IV—
P/IV—
Market implies +36.1%/yr vs model +15.0% · above model
AIXI
Xiao-I Corp
Valuation N/A
Technology Risk 35 · Moderate
Price$1.12
Model IV—
P/IV—
Market implies +49.2%/yr vs model +2.0% · above model
ALAR
Alarum Technologies Ltd.
Valuation N/A
Technology Risk 39 · Moderate
Price$1.81
Model IV—
P/IV—
Limited data — see page
ALLT
Allot Ltd.
Valuation N/A
Technology Risk 31 · Moderate
Price$7.82
Model IV—
P/IV—
Market implies +22.3%/yr vs model -2.4% · above model
ALOY
REALLOYS INC.
Valuation N/A
Basic Materials Risk 51 · Elevated
Price$12.95
Model IV—
P/IV—
Market implies +87.6%/yr vs model +0.0% · above model
AMBO
Ambow Education Holding Ltd.
Valuation N/A
Consumer Defensive Risk 27 · Moderate
Price$1.80
Model IV—
P/IV—
Market implies +36.5%/yr vs model +2.0% · above model
AMBR
Amber International Holding Ltd
Valuation N/A
Financial Services Risk 44 · Elevated
Price$1.31
Model IV—
P/IV—
Market implies +84.0%/yr vs model +2.0% · above model
AMZE
AMAZE HOLDINGS, INC.
Valuation N/A
Consumer Cyclical Risk 39 · Moderate
Price$0.25
Model IV—
P/IV—
Market implies +9.4%/yr vs model +3.7% · above model
ASPSZ
ALTISOURCE PORTFOLIO SOLUTIONS S.A.
Valuation N/A
Technology Risk 58 · Elevated
Price$0.19
Model IV—
P/IV—
Market implies -50.0%/yr vs model +2.0% · below model
ASTI
Ascent Solar Technologies, Inc.
Valuation N/A
Technology Risk 37 · Moderate
Price$3.32
Model IV—
P/IV—
Market implies +108.5%/yr vs model +2.0% · above model
ASYS
AMTECH SYSTEMS INC
Valuation N/A
Industrials Risk 31 · Moderate
Price$15.40
Model IV—
P/IV—
Market implies +25.0%/yr vs model +3.0% · above model
AURE
Aurelion Inc.
Valuation N/A
Financial Services Risk 55 · Elevated
Price$1.70
Model IV—
P/IV—
Market implies +43.6%/yr vs model +2.0% · above model
AXG
Solowin Holdings, Ltd.
Valuation N/A
Financial Services Risk 31 · Moderate
Price$2.60
Model IV—
P/IV—
Market implies +52.0%/yr vs model +2.0% · above model
AXTI
AXT INC
Valuation N/A
Technology Risk 32 · Moderate
Price$81.64
Model IV—
P/IV—
Market implies +91.8%/yr vs model +2.0% · above model
BAK
BRASKEM SA
Valuation N/A
Basic Materials Risk 46 · Elevated
Price$2.04
Model IV—
P/IV—
Limited data — see page
BBAI
BigBear.ai Holdings, Inc.
Valuation N/A
Technology Risk 41 · Elevated
Price$3.27
Model IV—
P/IV—
Market implies +63.6%/yr vs model +2.0% · above model
BBBY
BED BATH & BEYOND, INC.
Overvalued
Consumer Cyclical Risk 57 · Elevated
Price$4.27
Model IV$3.51
P/IV2.86
Premium +22% Return to IV: -17.9%
Market implies +8.7%/yr vs model +2.0% · above model
BGIN
BGIN BLOCKCHAIN Ltd
Valuation N/A
Financial Services Risk 27 · Moderate
Price$1.70
Model IV—
P/IV—
Market implies +41.5%/yr vs model +2.0% · above model
BGL
Blue Gold Ltd
Valuation N/A
Basic Materials Risk 31 · Moderate
Price$0.21
Model IV—
P/IV—
Market implies +18.8%/yr vs model +5.0% · above model
BIYA
Baiya International Group Inc.
Valuation N/A
Technology Risk 37 · Moderate
Price$2.65
Model IV—
P/IV—
Market implies -49.8%/yr vs model +7.8% · below model
BLFS
BIOLIFE SOLUTIONS INC
Valuation N/A
Healthcare Risk 46 · Elevated
Price$33.93
Model IV—
P/IV—
Market implies +51.2%/yr vs model +2.0% · above model
BLNE
Beeline Holdings, Inc.
Valuation N/A
Financial Services Risk 32 · Moderate
Price$1.01
Model IV—
P/IV—
Market implies +18.2%/yr vs model +2.0% · above model
BMNR
BITMINE IMMERSION TECHNOLOGIES, INC.
Valuation N/A
Financial Services Risk 28 · Moderate
Price$18.08
Model IV—
P/IV—
Market implies +107.5%/yr vs model +15.0% · above model
BMR
Beamr Imaging Ltd.
Valuation N/A
Technology Risk 31 · Moderate
Price$1.32
Model IV—
P/IV—
Market implies +55.9%/yr vs model +2.0% · above model
BNBX
BNB PLUS CORP.
Valuation N/A
Industrials Risk 35 · Moderate
Price$0.15
Model IV—
P/IV—
Market implies +1.6%/yr vs model +2.0% · in line
BNCWZ
CEA Industries Inc.
Fairly valued
Basic Materials Risk 27 · Moderate
Price$0.06
Model IV$0.07
P/IV1.75
Discount 11% Return to IV: +12.7%
Market implies -6.3%/yr vs model +0.0% · below model
BNKK
BONK, INC.
Valuation N/A
Consumer Defensive Risk 27 · Moderate
Price$1.08
Model IV—
P/IV—
Market implies +49.6%/yr vs model +2.0% · above model
BOXL
Boxlight Corp
Deeply undervalued
Consumer Defensive Risk 64 · High
Price$6.95
Model IV$40.61
P/IV0.79
Discount 83% Return to IV: +484.4%
Market implies -33.2%/yr vs model +2.0% · below model
BPYPP
Brookfield Property Partners L.P.
Valuation N/A
Real Estate
Price$16.04
Model IV—
P/IV—
Limited data — see page
BRN
BARNWELL INDUSTRIES INC
Overvalued
Energy Risk 43 · Elevated
Price$0.97
Model IV$0.75
P/IV1.39
Premium +29% Return to IV: -22.4%
Market implies -3.5%/yr vs model +0.0% · below model
BTCT
BTC Digital Ltd.
Valuation N/A
Financial Services Risk 51 · Elevated
Price$0.45
Model IV—
P/IV—
Market implies -7.5%/yr vs model +2.0% · below model
BTOG
BIT ORIGIN Ltd
Valuation N/A
Financial Services Risk 27 · Moderate
Price$0.82
Model IV—
P/IV—
Market implies +112.0%/yr vs model +2.0% · above model
BW
Babcock & Wilcox Enterprises, Inc.
Valuation N/A
Industrials Risk 37 · Moderate
Price$9.37
Model IV—
P/IV—
Market implies +89.0%/yr vs model +2.0% · above model
BWNB
Babcock & Wilcox Enterprises, Inc.
Valuation N/A
Industrials Risk 28 · Moderate
Price$25.16
Model IV—
P/IV—
Market implies +16.6%/yr vs model +2.0% · above model
BYND
BEYOND MEAT, INC.
Valuation N/A
Consumer Defensive Risk 68 · High
Price$0.54
Model IV—
P/IV—
Market implies +0.9%/yr vs model +2.0% · in line
CAN
Canaan Inc.
Valuation N/A
Financial Services Risk 34 · Moderate
Price$0.21
Model IV—
P/IV—
Market implies +23.4%/yr vs model +2.0% · above model
CANG
Cango Inc.
Valuation N/A
Financial Services Risk 50 · Elevated
Price$1.65
Model IV—
P/IV—
Market implies +54.5%/yr vs model +2.8% · above model
CCHH
CCH Holdings Ltd
Valuation N/A
Consumer Cyclical Risk 37 · Moderate
Price$1.39
Model IV—
P/IV—
Market implies +45.7%/yr vs model +2.0% · above model
CCM
Concord Medical Services Holdings Ltd
Valuation N/A
Healthcare Risk 27 · Moderate
Price$4.53
Model IV—
P/IV—
Market implies +16.1%/yr vs model +2.0% · above model
CCU
UNITED BREWERIES CO INC
Valuation N/A
Consumer Defensive Risk 43 · Elevated
Price$11.79
Model IV—
P/IV—
Limited data — see page
CGNT
Cognyte Software Ltd.
Valuation N/A
Technology Risk 40 · Elevated
Price$9.12
Model IV—
P/IV—
Market implies +30.1%/yr vs model +3.0% · above model
CHGG
CHEGG, INC
Valuation N/A
Consumer Defensive Risk 40 · Elevated
Price$0.84
Model IV—
P/IV—
Market implies +38.7%/yr vs model +2.0% · above model
CJMB
CALLAN JMB INC.
Deeply overvalued
Technology Risk 45 · Elevated
Price$2.37
Model IV$0.72
P/IV1.01
Premium +229% Return to IV: -69.6%
Market implies +14.0%/yr vs model +2.0% · above model
CMCM
Cheetah Mobile Inc.
Valuation N/A
Technology Risk 45 · Elevated
Price$3.11
Model IV—
P/IV—
Market implies +50.3%/yr vs model +7.5% · above model
CMTG
Claros Mortgage Trust, Inc.
Valuation N/A
Real Estate Risk 65 · High
Price$1.86
Model IV—
P/IV—
Market implies +30.5%/yr vs model +2.0% · above model
CNDT
CONDUENT Inc
Overvalued
Technology Risk 52 · Elevated
Price$1.70
Model IV$1.37
P/IV1.26
Premium +24% Return to IV: -19.5%
Market implies -0.4%/yr vs model +0.0% · in line
CNS
COHEN & STEERS, INC.
Valuation N/A
Financial Services Risk 56 · Elevated
Price$83.60
Model IV—
P/IV—
Market implies +40.6%/yr vs model +2.0% · above model
COHU
COHU INC
Valuation N/A
Healthcare Risk 48 · Elevated
Price$52.88
Model IV—
P/IV—
Market implies +35.4%/yr vs model +2.0% · above model
COOK
Traeger, Inc.
Valuation N/A
Technology Risk 69 · High
Price$61.34
Model IV—
P/IV—
Market implies +47.5%/yr vs model +2.0% · above model
CORZ
Core Scientific, Inc./tx
Valuation N/A
Financial Services Risk 37 · Moderate
Price$19.44
Model IV—
P/IV—
Market implies +52.4%/yr vs model +2.0% · above model
CORZZ
Core Scientific, Inc./tx
Valuation N/A
Financial Services Risk 34 · Moderate
Price$21.26
Model IV—
P/IV—
Market implies +145.2%/yr vs model +2.0% · above model
CPHI
CHINA PHARMA HOLDINGS, INC.
Valuation N/A
Healthcare Risk 27 · Moderate
Price$1.13
Model IV—
P/IV—
Market implies +3.3%/yr vs model +2.0% · in line
CRNC
Cerence Inc.
Valuation N/A
Technology Risk 45 · Elevated
Price$9.15
Model IV—
P/IV—
Market implies +18.0%/yr vs model -3.5% · above model
DGNX
Diginex Ltd
Valuation N/A
Technology Risk 50 · Elevated
Price$1.32
Model IV—
P/IV—
Limited data — see page
DHT
DHT Holdings, Inc.
Valuation N/A
Industrials Risk 43 · Elevated
Price$18.76
Model IV—
P/IV—
Limited data — see page